Washington, DC – Farragut Capital Partners, Inc. (“Farragut”) is pleased to announce the closing of a $4.5 million subordinated debt investment in Wisconsin Pharmacal Co., LLC (the “Company”) in partnership with management. Proceeds from the transaction were used to refinance existing debt.
Founded over 100 years ago and based near Milwaukee, Wisconsin Pharmacal is a manufacturer and distributor of consumer products to the outdoor recreation, first aid, and over-the-counter personal care and hygiene markets. The Company provides private label products to leading drug store and big box retailers in addition to products sold under its own brands, which include MG217 psoriasis products, vH Essentials feminine care products, and Potable Aqua water purification tablets.
“We’re excited to partner with Jeff and his team at Wisconsin Pharmacal,” said Phil McNeill, Managing Partner of Farragut. “The Company is already a leader in a variety of niche product categories, and we look forward to supporting them as they continue to grow the existing portfolio and through the addition of other specialty brands.”